ChromaDex(CDXC) - 2025 Q4 - Earnings Call Transcript
ChromaDexChromaDex(US:CDXC)2026-03-04 22:32
Financials
Slide

Niagen Bioscience (NasdaqCM:CDXC) Q4 2025 Earnings call March 04, 2026 04:30 PM ET Company ParticipantsAndrew Shao - SVP of Global Regulatory and Scientific AffairsJeffrey Cohen - Managing Director of Equity ResearchKendall Knysch - Senior Director of Publicity and Public RelationsOzan Pamir - CFORam Selvaraju - Managing Director of Equity ResearchRob Fried - CEOSusan Anderson - Managing DirectorConference Call ParticipantsSean McGowan - Managing Director and Senior Research AnalystOperatorLadies and gentle ...